Freeman Spogli Institute for International Studies Center for Health Policy/Center for Primary Care and Outcomes Research Stanford University


News and commentary


Photo of Mark Hlatky

Mark A. Hlatky, MD

Professor of Health Research and Policy and of Medicine (Cardiovascular Medicine) and Stanford Health Policy Fellow

View Mark Hlatky's bio, list of research, recent publications and events »


Display news from  

April 7th, 2009

Hlatky's coronary disease treatment comparison study continues to capture global press coverage

in the news

Faculty fellow Mark Hlatky continues to garner media coverage for his Lancet article comparing coronary artery bypass surgery and percutaneous coronary interventions for multivessel disease. Featured in hundreds of publications worldwide, Hlatky is also interviewed in the April 4th Lancet podcast.




March 7th, 2006

Statins, beta-blockers reduce risk of heart attack, study finds

Press Release

Taking prescription beta blocker or statin drugs may boost the chances of having only mild chest pain instead of a heart attack as the first symptom of heart disease, according to a study co-authored by CHP/PCOR researchers. +HTML+
Read more »



October 6th, 2005

Pricey defibrillators may be worth every penny, finds study in New England Journal

Press Release

A study by CHP/PCOR researchers, published in the Oct. 6 issue of the New England Journal of Medicine, finds that the implantable cardioverter defibrillator - one of the most expensive medical devices on the market - is a relatively cost-effective way to help prevent sudden cardiac deaths in certain patients. +HTML+
Read more »



August 5th, 2005

Hlatky quoted in NY Times article on concerns over defibrillators' cost, possible overuse

in the news: New York Times on August 2, 2005

CHP/PCOR fellow Mark Hlatky provides comment for an Aug. 2 New York Times article on mounting concerns about the high cost and possible overuse of implantable cardiac defibrillators as use of the device expands. Read more »



October 8th, 2004

In news series, fellows discuss need to balance medical technology's costs, benefits

in the news: St. Louis Post-Dispatch on September 25, 2004

CHP/PCOR fellows Laurence C. Baker and Mark A. Hlatky provide comment for a lengthy St. Louis Post-Dispatch article that examines the role of medical technology in the nation's rising healthcare costs, and the need to balance individual benefits and societal costs when making patient care decisions. Read more »




« Earlier news | Most current news articles »»



Select news articles from:
«

April 2014

»

S

M

T

W

T

F

S

  

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

29

30

   

News around the web

CABG, PCI debate continues with new research, emerging technologies
Research performed in 2009 by Mark Hlatky, MD, professor of health research and policy and of medicine, Stanford University, and colleagues examined the ...
October 1, 2010 in Cardiology Today

Statins Could Prevent More Strokes, Heart Attacks: Analysis
... Dr. Mark Hlatky, professor of health research and policy and of cardiovascular medicine at Stanford University School of Medicine in Stanford, Calif., ...
September 27, 2010 in BusinessWeek

Study: Putting More People on Cholesterol-Lowering Drugs Could Save Money
Now scientists at Stanford University report an economic benefit to taking statins: putting more patients on the cholesterol medication may be a ...
September 27, 2010 in TIME

Wider statin use may be cost-effective way to prevent heart attack, stroke
Whether expanding statin use as a preventive strategy would be cost-effective, though, remained an unanswered question - and Stanford researchers did their ...
September 27, 2010 in Scope (blog)